The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 37, 2008, Pages 14169-14174

  Pibiri, Fabio ^a   Kozikowski, Alan P ^b   Pinna, Graziano ^a   Auta, James ^a   Kadriu, Bashkim ^a   Costa, Erminio ^a   Guidotti, Alessandro ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

GABAA receptor; Neurotoxicity

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ATROPINE; DIAZEPAM; DYFLOS; HUPERZINE A; IMIDAZENIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CONVULSION; DRUG POTENCY; DRUG SAFETY; INTOXICATION; MALE; MORTALITY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEDATION; SEIZURE;

ANIMALS; BENZODIAZEPINES; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; IMIDAZOLES; ISOFLUROPHATE; LETHAL DOSE 50; LOCOMOTION; MALE; MICE; SEIZURES; SESQUITERPENES;

MUS;

EID: 52949084679     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0807172105     Document Type: Article

References (42)

1. Coupland R, Leins KR (2005) Science and prohibited weapons. Science 308:1841.
2. Romano JA, King JM (2001) Psychological casualties resulting from chemical and biological weapons. Mil Med 166:21-22.
3. Karalliedde L, Senanayake N (1989) Organophosphorus insecticide poisoning. Br J Anaesth 63:736-750.
4. Buckley NA, Roberts D, Eddleston M (2004) Overcoming apathy in research on organophosphate poisoning. BMJ 329:1231-1233.
5. Lallement G et al. (2002) Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 23:1-5.
6. Auta J, Costa E, Davis J, Guidotti A (2004) Imidazenil: A potent and safe protective agent against diisopropyl fluorophosphate toxicity. Neuropharmacology 46:397-403.
7. Lemercier G, Carpentier P, Sentenac-Roumanou H, Morelis P (1983) Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol 61:123-129.
8. Miller SA, Blick DW, Kerenyi SZ, Murphy MR (1993) Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacol Biochem Behav 44:343-347.
9. Kerenyi SZ, Murphy MR, Hartgraves SL (1990) Toxic interactions between repeated soman and chronic pyridostigmine in rodents. Pharmacol Biochem Behav 37:267-271.
10. Grunwald J, Raveh L, Doctor BP, Ashani Y (1994) Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 54:991-997.
11. Coelho F, Birks J (2001) Physostigmine for Alzheimer's disease. Cochrane Database Syst Rev 2:CD001499.
12. Philippens IH, Wolthuis OL, Busker RW, Langenberg JP, Melchers BP (1996) Side effects of physostigmine as a pretreatment in guinea pigs. Pharmacol Biochem Behav 55:99-105.
13. Philippens IH, et al. (1998) Subchronic physostigmine pretreatment in guinea pigs: Effective against soman and without side effects. Pharmacol Biochem Behav 59:1061-1067.
14. Meshulam Y, Davidovici R, Wengier A, Levy A (1995) Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea pigs. J Appl Toxicol 15:263-266.
15. Philippens IH, Melchers BP, Olivier B, Bruijnzeel PL (2000) Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav 65:175-182.
16. Anderson DR, et al. (1994) Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam Appl Toxicol 22:588-593.
17. Janowsky DS (2002) Central anticholinergics to treat nerve agent poisoning. Lancet 359:265-266.
18. Lallement G et al. (2001) Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness toward blood-brain barrier permeability. Drug Chem Toxicol 24:151-164.
19. Lallement G, Foquin A, Dorandeu F, Baubichon D, Carpentier P (2001) Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity. Drug Chem Toxicol 24:165-180.
20. Dawson RM (1994) Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14:317-331.
21. Steppuhn KG, Turski L (1993) Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 90:6889-6893.
22. Kozikowski AP, et al. (1991) Delineating the pharmacophoric elements of huperzine A: Importance of the unsaturated three-carbon bridge to its AChE inhibitory activity. J Med Chem 34:3399-3402.
23. Ashani Y, Peggins JO, III, Doctor BP (1992) Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 184:719-726.
24. Tonduli LS, Testylier G, Masqueliez C, Lallement G, Monmaur P (2001) Effects of huperzine used as pretreatment against soman-induced seizures. Neurotoxicology 22:29-37.
25. Guidotti A, et al. (2005) GABAergic dysfunction in schizophrenia: New treatment strategies on the horizon. Psychopharmacology (Bere) 180:191-205.
26. A receptors. J Pharmacol Exp Ther 266:1018-1028.
27. A receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270:1262-1269.
28. A receptors on complex behavioral processes in monkeys. Behav Pharmacol 6:323-332.
29. Auta J, Guidotti A, Costa E (2000) Imidazenil prevention of alprazolam-induced acquisition deficit in patas monkeys is devoid of tolerance. Proc Natl Acad Sci USA 97:2314-2319.
30. A receptors. Handbook of Experimental Pharmacology, Mohler H, ed (Springer, Berlin), Vol 150, pp 227-250.
31. Impagnatiello F, et al. (1996) Modifications of γ-aminobutyric acid A receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49:822-831.
32. Rump S, et al. (2000) Effects of imidazenil, a new benzodiazepine receptor partial agonist, in the treatment of convulsions in organophosphate intoxications. Neurotox Res 2:17-22.
33. Thompson DM, Auta J, Guidotti A, Costa E (1995) Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys. J Pharmacol Exp Ther 273:1307-1312.
34. Qian BC, et al. (1995) Pharmacokinetics of tablet huperzine A in six volunteers. Acta Pharmacol Sin 16:396-398.
35. Broomfield CA, et al. (1991) Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259:633-638.
36. Gordon RK et al. (2001) The NMDA receptor ion channel: A site for binding of huperzine A. J Appl Toxicol 21:S47-S51.
37. Costa E, Guidotti A (1996) Benzodiazepines on trial: A research strategy for their rehabilitation. Trends Pharmacol Sci 17:192-200.
38. Rudolph U, et al. (1999) Benzodiazepine actions mediated by specific γ-aminobutyric acid (A) receptor subtypes. Nature 401:796-800.
39. Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G (2008) Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci USA 105:5567-5572.
40. Blanchard RJ, Blanchard DC (1969) Passive and active reactions to fear-eliciting stimuli. J Comp Physiol Psychol 68:129-135.
41. Pinna G, Galici R, Schneider HH, Stephens DN, Turski L (1997) Alprazolam dependence prevented by substituting with the β-carboline abecarnil. Proc Natl Acad Sci USA 94:2719-2723.
42. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephal Clin Neurophysiol 32:281-294.